Global Top 25 Companies in the Breast Ultrasound Market by Transpire Insight

By Transpire Insight

---

Description

According to a research report published by Transpire Insight, the global breast ultrasound market size is projected to grow from USD 4.10 billion in 2026 to USD 7.80 billion by 2035, at a CAGR of 10.14% during the forecast period 2026-2035. Aggressive dense breast notification laws, coupled with the increasing prevalence of breast cancer around the world, are directly impacting adoption. In addition, continuous innovations in operator-independent Automated Breast Ultrasound Systems (ABUS) eliminate typical manual scanning inconsistencies, driving clinical demand.

Introduction

Breast ultrasound devices are witnesses to the global market's rapid growth, driven by the rising incidence of breast cancer and the increasing emphasis on early screening initiatives. In addition to traditional mammography, which is still a major diagnostic tool, the effectiveness of this imaging method is greatly diminished by the presence of dense breast tissue, in which overlapping structures can obscure any abnormalities. This is why there has been a growing need for advanced ultrasound modalities, especially automated, 3D, and AI-powered platforms, to fill this important clinical need. This change in structure ensures that this will be widely used in advanced medical facilities throughout the world.

Recent Development News

• June 2026: QT Imaging reported low clinical variability for its automated 3D breast scanner biomarkers, proving its reliability for dense tissue imaging.

• January 2026: Emirates Health Services unveiled the Middle East's premier radiation-free 3D breast diagnostic system to prioritize early detection workflows.

Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight

Transpire Insight provides comprehensive, data-driven market intelligence to support smarter business decisions. Our research is rooted in comprehensive analysis, authoritative predictions, and industry expertise, enabling organizations to make informed decisions in rapidly evolving markets. In-depth analysis of market segmentation, competitive positioning, regional trends, and emerging investment opportunities in high-growth areas. We blend accuracy with actionable intelligence, empowering companies to uncover new avenues for growth, bolster strategic decision-making, and stay ahead in a dynamic global market. 

Download the exclusive Breast Ultrasound Market sample report today to uncover expert insights, emerging trends, and the opportunities defining the future of the industry.

Breast Ultrasound Market Size & Statistics

• The market size for breast ultrasound is estimated at USD 4.10 billion in 2026.
• The market size is going to expand at a CAGR of 10.14% between 2026 and 2035.
• The global breast ultrasound market size is anticipated to reach USD 7.80 billion.
• North America is estimated to generate the highest demand during the forecast period, with a growth of 35.6% in the breast ultrasound market.
• Asia-Pacific is projected to grow the fastest during the forecast period, at an 8.4% CAGR, in the breast ultrasound market.

Regional Growth and Demand Analysis by Transpire Insight:

North America's leadership rests on early and consistent adoption of automated whole-breast imaging, backed by dense-breast notification mandates across most U.S. states and strong reimbursement support from private insurers and Medicare/Medicaid alike. Leading academic cancer centers have folded AI-enhanced reading tools into routine screening pathways, while Canada's provincial health systems continue expanding access to remote and rural populations. Mexico's private hospital networks are also leaning on automated systems to serve medical-tourism patients seeking comprehensive breast-imaging packages. This infrastructure advantage was reinforced in March 2026, when GE HealthCare secured FDA premarket approval for its Invenia ABUS Premium system, an AI-powered platform that cut scan time by 40% and accelerated adoption across U.S. hospital networks.

Asia Pacific's rapid growth is being driven by expanding hospital and diagnostic-lab infrastructure, rising breast cancer awareness campaigns, and government-backed screening initiatives across China, India, and Japan. China's growth is anchored in large-scale hospital procurement and a fast-expanding medical device manufacturing base, while Japan continues to lead in AI-assisted breast ultrasound research. India stands out for extending access into underserved areas. Through 2026, state health departments have deployed automated breast ultrasound (ABU) systems in mobile screening vans, bringing dense-tissue screening to rural populations that previously lacked radiology infrastructure.

Top 15 Trends in the Breast Ultrasound Market 

• Rising adoption of AI-powered breast ultrasound diagnostic platforms.
• Automated breast ultrasound systems are gaining share over conventional handheld devices.
• Dense-breast notification laws are driving supplemental screening demand.
• Contrast-enhanced ultrasound reduces unnecessary biopsy rates.
• Mobile and portable ultrasound units are expanding rural screening access.
• Hospitals remain the dominant end-use setting for breast imaging.
• Diagnostic imaging centers and mobile screening units are growing fastest.
• North America leads the market in reimbursement and screening infrastructure.
• Asia Pacific is emerging as the fastest-growing regional market.
• Strategic product launches strengthen competitive positioning among device makers.
• Integration of cloud-based reading hubs for radiologist workflows.
• Rising breast cancer incidence fueling global screening volumes.
• Medical tourism boosting ABUS adoption in private hospitals.
• Workforce shortages accelerate demand for AI-assisted scanning tools.
• Government screening programs expanding access in underserved regions.

Proceed to Checkout to purchase the exclusive Breast Ultrasound Market report and gain instant access to in-depth market intelligence, strategic analysis, and future growth opportunities.

1. AI-Powered Diagnostic Platforms
   Artificial intelligence is increasingly embedded in breast ultrasound systems, automating lesion detection and helping radiologists interpret dense-tissue scans faster, more accurately, and far more consistently.
2. ABUS Gaining Share over Conventional Systems
   Automated breast ultrasound systems are steadily gaining share over conventional handheld scanning as hospitals prioritize standardized, reproducible whole-breast imaging that reduces operator dependency during screening.
3. Dense-Breast Notification Laws
   Mandatory dense-breast notification laws across several countries are pushing more women toward supplemental ultrasound screening, since dense tissue significantly lowers mammography's ability to detect tumors.
4. Contrast-Enhanced Ultrasound
   Contrast-enhanced ultrasound is gaining clinical traction in breast imaging, as microbubble-based techniques improve lesion specificity and help radiologists avoid unnecessary biopsies in fairly ambiguous cases.
5. Asia Pacific's Fastest-Growing Status
   Asia Pacific is emerging as the fastest-growing breast ultrasound market, driven by rapidly expanding hospital infrastructure and government-backed screening programs across China, India, and Japan.
6. Rising Breast Cancer Incidence
   The rising global burden of breast cancer, now the most commonly diagnosed cancer among women worldwide, continues to drive steadily higher screening volumes and demand.

Top 25 Companies Leading the Breast Ultrasound Market 

• Hitachi Ltd.
• Hologic Inc.
• Koninklijke Philips N.V.
• Samsung Medison
• Mindray Medical
• Fujifilm Holdings
• Delphinus Medical Technologies
• SonoCiné Inc.
• QT Ultrasound (QT Imaging)
• SuperSonic Imagine
• Esaote SpA
• Carestream Health
• Clarius Mobile Health
• GE HealthCare Technologies Inc.
• Canon Medical Systems Corporation
• Siemens Healthineers AG
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Konica Minolta Healthcare Americas, Inc.
• Toshiba Medical Systems Corporation (now part of Canon Medical)
• BK Medical (Altaris, part of GE HealthCare)
• Esaote North America, Inc.
• Alpinion Medical Systems Co., Ltd.
• CHISON Medical Technologies Co., Ltd.
• SonoScape Medical Corp.

Customize the exclusive Breast Ultrasound Market report today to receive tailored insights, country-specific analysis, and business-focused market intelligence.

1. Hitachi Ltd.

Advanced Arietta ultrasound platforms introduce high-resolution structural tissue mapping to radiology departments.

Founded: 1910 | HQ: Tokyo, Japan.

Why It Ranks: Pioneers in elastomer tissue evaluation software to reduce painful and unnecessary biopsies.

Regional Dominance: Maintains an immovable leadership position inside expansive Asian hospital networks.

Product Line: Arietta series systems provide incredible high-definition diagnostic imaging for deep tissue.

2. Hologic Inc.

Its cutting-edge SuperSonic and hand-held multi-modality technologies actively revolutionize multi-parametric breast tissue assessment.

Founded: 1985 | HQ: Massachusetts, USA.

Why It Ranks: Remains a premier global authority focused entirely on female wellness technologies.

Regional Dominance: Dictates the market landscape across dense North American screening clinics.

Product Line: SuperSonic MACH systems incorporate premium breast elasticity profiling tools for clinicians.

3. Koninklijke Philips N.V.

Integrated artificial intelligence solutions continuously enhance diagnostic confidence by standardizing complex workflows.

Founded: 1891 | HQ: Amsterdam, Netherlands.

Why It Ranks: Seamlessly integrates smart anatomical quantification software into traditional workflow designs.

Regional Dominance: Captures an expansive market share spanning Western European healthcare infrastructure.

Product Line: EPIQ and Affiniti platforms utilize proprietary software for targeted lesion analysis.

4. Samsung Medison

Premium visual rendering engines offer remarkably vivid spatial clarity for subtle structural variations.

Founded: 1985 | HQ: Seoul, South Korea.

Why It Ranks: Leads deep-learning integration by deploying rapid automated breast lesion classification tools.

Regional Dominance: Rapidly captures high-growth market segments throughout evolving Asia-Pacific territories.

Product Line: RS85 Prestige systems prioritize highly detailed and microscopic tissue structure analysis.

5. Mindray Medical

Cost-effective cart-based platforms significantly democratize localized point-of-care ultrasound applications globally.

Founded: 1991 | HQ: Shenzhen, China.

Why It Ranks: Delivers an exceptional balance between premium diagnostic capabilities and affordable hospital acquisition costs.

Regional Dominance: Holds undisputed structural market control across public Chinese medical networks.

Product Line: The Resona and Consona series bring reliable diagnostic software to standard clinical teams.

6. Fujifilm Holdings

Combining Sonosite point-of-care speed with premium radiology consoles delivers versatile clinical diagnostics.

Founded: 1934 | HQ: Tokyo, Japan.

Why It Ranks: Uniquely merges comprehensive digital mammography systems with specialized high-frequency complementary ultrasounds.

Regional Dominance: Possesses powerful, diversified distribution pipelines running across European and Asian markets.

Product Line: Elixir and Arietta platforms provide comprehensive diagnostic coverage for multi-department setups.

7. Delphinus Medical Technologies

The highly innovative SoftVue platform redefines how dense breast tissue receives routine care.

Founded: 2010 | HQ: Michigan, USA.

Why It Ranks: Patented safe underwater acoustic ring technology scans tissue across 360 degrees.

Regional Dominance: Experiences continuous, rapid installation growth inside modern American imaging facilities.

Product Line: SoftVue 3D tomography delivers compression-free screening options for dense-breasted patients.

8. SonoCiné Inc.

Automated tracking software transforms standard handheld units into precise, operator-independent screening tools.

Founded: 1999 | HQ: Nevada, USA.

Why It Ranks: Invented high-precision robotic probe stabilization to prevent missing hidden internal micro-lesions.

Regional Dominance: Operates extensively within prominent specialized oncology screening facilities across North America.

Product Line: Automated Whole Breast Ultrasound (AWBU) attachments seamlessly optimize pre-existing facility hardware.

9. QT Ultrasound (QT Imaging)

Transmission-based acoustic technologies produce unmatched structural clarity without painful physical compression or radiation.

Founded: 2011 | HQ: California, USA.

Why It Ranks: True speed-of-sound transmission algorithms build distinct, highly comprehensive multi-dimensional tissue maps.

Regional Dominance: Forging extensive commercial partnerships to expand across expanding Middle Eastern markets.

Product Line: QT Breast Scanners offer highly accurate, radiation-free solutions for dense anatomy.

10. SuperSonic Imagine

Proprietary ShearWave elastography measures absolute tissue stiffness in real-time for immediate tumor evaluation.

Founded: 2005 | HQ: Aix-en-Provence, France.

Why It Ranks: Transformed traditional diagnostic workflows by introducing precise, quantitative tissue hardness metrics.

Regional Dominance: Retains strong, highly specialized usage across dedicated academic research clinics worldwide.

Product Line: Aixplorer systems provide highly detailed real-time physiological profiling for oncology specialists.

Schedule a meeting with our market experts to discuss the exclusive Breast Ultrasound Market report and identify the best research solution for your organization.

Conclusion

Overall, breast ultrasound is positioned to play a key role in the much-needed shift in cancer screening. Manual workflows are gradually replaced by automated, AI-assisted and 3D-architectural workflows, as regulatory requirements continue to demand clear and transparent diagnoses even in dense tissue. The partnership of well-known healthcare giants and niche diagnostic trailblazers makes screening tools without radiation, comfortable, and incredibly accurate commonplace throughout the world. This continuous technological development will keep saving lives by early detection, reduce the cost of healthcare, and provide a higher diagnostic accuracy.